Organization

Industry Advisory Board

The Industry Advisory Board (IAB) provides strategic guidance, sets research priorities, and connects the BRAIN Center's work to industry needs across the neurotechnology sector.
Stanley Chang

IAB Chair

Stanley Chang

President and Chief Product Officer, Scialiva

Stanley brings a distinctive blend of biotechnology, high-tech, and legal expertise. As an executive, entrepreneur, investor, and co-founder in biotech and high-tech ventures, he managed business operations and P&L responsibilities while strategically integrating diverse disciplines while driving innovation. Stanley has hands-on experience in areas critical to the IUCRC-BRAIN mission, including diagnostic tests, AI-driven algorithms, encryption, and error correction systems. Additionally, his legal background as an attorney specializing in intellectual property and transactional matters positions him to navigate complex industry-academic collaborations.

Craig Mermel

IAB Co-Chair

Craig Mermel

President and Chief Product Officer, Precision Neuroscience

"Everyone deserves an unrestricted life. Restoring freedom through brain-computer interfaces, AI, smart exoskeletons, and other neuroengineering innovations can help provide breakthrough treatments to people with neurological conditions. At the IUCRC BRAIN – a leading industry-university-government partnership – industry members collaborate with world class researchers at premier institutions worldwide to advance the state of the art in neurotechnology.

A modest investment into BRAIN membership gives industry members the leverage and big returns that would not be possible otherwise. We get to work side by side with billion-dollar neurotech firms, interact with federal regulatory agencies, hire highly skilled students, have a say in selecting cutting edge projects, have the choice to commercialize novel devices and be a part of the neurotechnology revolution: Neuroengineered for What's is Next."